JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seguin, J. R.
Right arrow Articles by Chaptal, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seguin, J. R.
Right arrow Articles by Chaptal, P. A.

The Journal of Thoracic and Cardiovascular Surgery, Vol 104, 748-751, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Fibrin sealant for early repair of acquired ventricular septal defect

JR Seguin, JM Frapier, P Colson and PA Chaptal
Thoracic and Cardiovascular Surgery Unit, C.H.U. Hopital Saint Eloi, Montpellier, France.

The trend toward early operation for acquired ventricular septal defects exposes the patient to major perioperative bleeding and residual shunt because of the fragility of the recently necrosed myocardium. To reduce these complications we have used a fibrin sealant to reinforce the cardiac tissues in addition to the usual closure of the defect with a Dacron patch through a left ventricular septum around the defect, area. During cardiac arrest fibrin sealant is applied on the ventricular septum around the defect, between the septum and the patch, and on the edges of the ventriculotomy. This technique was used in three patients (mean age 68.2 years) operated on for an acquired ventricular septal defect within 4 days of the infarction and within 24 hours of the occurrence of the defect. Low postoperative bleeding, absence of recurrent shunt, and good ventricular function indicated satisfactory surgical result in all three patients. We suggest that the use of fibrin sealant during operations for acquired ventricular septal defects, by reinforcing the necrotic and fragile tissues, may reduce perioperative bleeding and assure a more solid implantation of the patch.


This article has been cited by other articles:


Home page
Card Surg AdultHome page
A. K. Agnihotri, J. C. Madsen, and W. M. Daggett Jr
Surgical Treatment of Complications of Acute Myocardial Infarction: Postinfarction Ventricular Septal Defect and Free Wall Rupture
Card. Surg. Adult, January 1, 2008; 3(2008): 753 - 784.
[Full Text]


Home page
Card Surg AdultHome page
A. K. Agnihotri, J. C. Madsen, and W. M. Daggett Jr.
Surgical Treatment of Complications of Acute Myocardial Infarction: Postinfarction Ventricular Septal Defect and Free Wall Rupture
Card. Surg. Adult, January 1, 2003; 2(2003): 681 - 714.
[Full Text]


Home page
CLIN APPL THROMB HEMOSTHome page
P. F. Glidden, C. Malaska, and S. W. Herring
Thromboelastograph Assay for Measuring the Mechanical Strength of Fibrin Sealant Clots
Clinical and Applied Thrombosis/Hemostasis, October 1, 2000; 6(4): 226 - 233.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. Musumeci, V. Shukla, C. Mignosa, G. Casali, and S. Ikram
Early Repair of Postinfarction Ventricular Septal Defect With Gelatin-Resorcin-Formol Biological Glue
Ann. Thorac. Surg., August 1, 1996; 62(2): 486 - 488.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The American Association for Thoracic Surgery.